Long noncoding RNA Arid2-IR is a novel therapeutic target for renal inflammation

Molecular Therapy

Volumn 23, Issue 6, 2015, Pages 1034-1043

  Zhou, Qin ^a,b   Huang, Xiao R ^a   Yu, Jianwen ^a,b   Yu, Xueqing ^b   Lan, Hui Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LONG UNTRANSLATED RNA; RNA ARID2 IR; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; SMAD3 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; ZIPZAP PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; INTRON; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; MALE; MOUSE; NEPHRITIS; NONHUMAN; OBSTRUCTIVE NEPHROPATHY; PROMOTER REGION; RNA SEQUENCE; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; GENE SILENCING; GENE THERAPY; GENETICS; INFLAMMATION; KIDNEY; KIDNEY DISEASES; METABOLISM; PROCEDURES; SEQUENCE ANALYSIS;

MUS;

ANIMALS; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; GENETIC THERAPY; INFLAMMATION; INTERLEUKIN-1BETA; KIDNEY; KIDNEY DISEASES; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; RNA, LONG NONCODING; SEQUENCE ANALYSIS, RNA; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84930180712     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2015.31     Document Type: Article

References (32)

1. Chung, AC, Yu, X and Lan, HY (2013). MicroRNA and nephropathy: emerging concepts. Int J Nephrol Renovasc Dis 6: 169-179
2. Lorenzen, JM, Haller, H and Thum, T (2011). MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol 7: 286-294
3. Li, R, Chung, AC, Dong, Y, Yang, W, Zhong, X and Lan, HY (2013). The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-?/Smad3-Azin1 pathway. Kidney Int 84: 1129-1144
4. Ponting, CP, Oliver, PL and Reik, W (2009). Evolution and functions of long noncoding RNAs. Cell 136: 629-641
5. Wang, KC and Chang, HY (2011). Molecular mechanisms of long noncoding RNAs. Mol Cell 43: 904-914
6. Spizzo, R, Almeida, MI, Colombatti, A and Calin, GA (2012). Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene 31: 4577-4587
7. Wapinski, O and Chang, HY (2011). Long noncoding RNAs and human disease. Trends Cell Biol 21: 354-361
8. Zhou, Q, Chung, AC, Huang, XR, Dong, Y, Yu, X and Lan, HY (2014). Identification of novel long noncoding RNAs associated with TGF-?/Smad3-mediated renal inflammation and fibrosis by RNA sequencing. Am J Pathol 184: 409-417
9. Huang, YS, Hsieh, HY, Shih, HM, Sytwu, HK and Wu, CC (2014). Urinary Xist is a potential biomarker for membranous nephropathy. Biochem Biophys Res Commun 452: 415-421
10. Lan, HY (2011). Diverse roles of TGF-?/Smads in renal fibrosis and inflammation. Int J Biol Sci 7: 1056-1067
11. Meng, XM, Huang, XR, Chung, AC, Qin, W, Shao, X, Igarashi, P et al. (2010). Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis. J Am Soc Nephrol 21: 1477-1487
12. Chung, AC, Huang, XR, Zhou, L, Heuchel, R, Lai, KN and Lan, HY (2009). Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. Nephrol Dial Transplant 24: 1443-1454
13. Chen, HY, Huang, XR, Wang, W, Li, JH, Heuchel, RL, Chung, AC et al. (2011). The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential. Diabetes 60: 590-601
14. Inazaki, K, Kanamaru, Y, Kojima, Y, Sueyoshi, N, Okumura, K, Kaneko, K et al. (2004). Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction. Kidney Int 66: 597-604
15. Liu, Z, Huang, XR and Lan, HY (2012). Smad3 mediates ANG II-induced hypertensive kidney disease in mice. Am J Physiol Renal Physiol 302: F986-F997
16. Loots, GG and Ovcharenko, I (2004). rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res 32(Web Server issue): W217-W221
17. Sui, W, Li, H, Ou, M, Tang, D and Dai, Y (2012). Altered long non-coding RNA expression profile in patients with IgA-negative mesangial proliferative glomerulonephritis. Int J Mol Med 30: 173-178
18. Yang, X, Letterio, JJ, Lechleider, RJ, Chen, L, Hayman, R, Gu, H et al. (1999). Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 18: 1280-1291
19. Ashcroft, GS, Yang, X, Glick, AB, Weinstein, M, Letterio, JL, Mizel, De et al. (1999). Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1: 260-266
20. Huang, XR, Chung, AC, Yang, F, Yue, W, Deng, C, Lau, CP et al. (2010). Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling. Hypertension 55: 1165-1171
21. Daly, AC, Vizán, P and Hill, CS (2010). Smad3 protein levels are modulated by Ras activity and during the cell cycle to dictate transforming growth factor-beta responses. J Biol Chem 285: 6489-6497
22. Park, JI, Lee, MG, Cho, K, Park, BJ, Chae, KS, Byun, DS et al. (2003). Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Oncogene 22: 4314-4332
23. Guttman, M and Rinn, JL (2012). Modular regulatory principles of large non-coding RNAs. Nature 482: 339-346
24. Khalil, AM, Guttman, M, Huarte, M, Garber, M, Raj, A, Rivea Morales, D et al. (2009). Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 106: 11667-11672
25. rom, UA, Derrien, T, Beringer, M, Gumireddy, K, Gardini, A, Bussotti, G et al. (2010). Long noncoding RNAs with enhancer-like function in human cells. Cell 143: 46-58
26. Li, M, Zhao, H, Zhang, X, Wood, LD, Anders, RA, Choti, MA et al. (2011). Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 43: 828-829
27. Xu, F, Flowers, S and Moran, E (2012). Essential role of ARID2 protein-containing SWI/SNF complex in tissue-specific gene expression. J Biol Chem 287: 5033-5041
28. Yan, Z, Cui, K, Murray, DM, Ling, C, Xue, Y, Gerstein, A et al. (2005). PBAF chromatinremodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes. Genes Dev 19: 1662-1667
29. Lan, HY, Mu, W, Tomita, N, Huang, XR, Li, JH, Zhu, HJ et al. (2003). Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 14: 1535-1548
30. Qin, W, Chung, AC, Huang, XR, Meng, XM, Hui, DS, Yu, CM et al. (2011). TGF-?/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol 22: 1462-1474
31. Zhong, X, Chung, AC, Chen, HY, Meng, XM and Lan, HY (2011). Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 22: 1668-1681
32. Chen, HY, Zhong, X, Huang, XR, Meng, XM, You, Y, Chung, AC et al. (2014). MicroRNA-29b inhibits diabetic nephropathy in db/db mice. Mol Ther 22: 842-853